Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Athira Pharma Inc ATHA

Healthcare
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company. It focuses on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline consists of both blood brain barrier permeable and peripherally restricted drug candidates for the central nervous system (CNS), peripheral nervous system, and other indications. Its lead candidate... see more

Recent & Breaking News (NDAQ:ATHA)

FINAL DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA

Newsfile August 23, 2021

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Athira Pharma, Inc. (ATHA)

Business Wire August 23, 2021

ATHIRA PHARMA 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors with Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA

Newsfile August 22, 2021

Athira Class Action Reminder

Newsfile August 22, 2021

FINAL NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHA

PR Newswire August 21, 2021

ATHIRA PHARMA 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA

Business Wire August 20, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATHA, QFIN and ANVS

Accesswire August 20, 2021

Athira Shareholder Notice

Newsfile August 20, 2021

ATHA 4-DAY DEADLINE ALERT: Hagens Berman Encourages Athira Pharma (ATHA) Investors with Losses to Contact Firm's Attorneys Before Application Deadline in Securities Fraud Class Action

Newsfile August 20, 2021

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors

PR Newswire August 20, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of HMPT, ATHA and VIEW

Accesswire August 20, 2021

TUESDAY DEADLINE NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Athira Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Newsfile August 20, 2021

LAWSUITS FILED AGAINST JRVR, ATHA and BLCT - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

Accesswire August 20, 2021

ATHIRA PHARMA SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess Of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Athira Pharma, Inc. - ATHA

Newsfile August 19, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA

PR Newswire August 19, 2021

Athira Shareholder Alert

Newsfile August 19, 2021

FINAL DEADLINE NOTICE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Athira Pharma, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA

Newsfile August 19, 2021

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SRAC, ATHA and ANVS

Accesswire August 19, 2021

DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Athira Pharma, Inc. Securities Fraud Class Action Lawsuit

PR Newswire August 19, 2021

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SRAC, JRVR and ATHA

Accesswire August 19, 2021